The University Hospital of Basel, in Basel, is one of the five university hospitals of Switzerland. Since 1842 it is located in a former palace, the Markgräflerhof. USB brings together 50 clinics, units and institutes all working together in an interdisciplinary manner and employs a staff of about 5000.

There are 773 beds in Universitätsspital Basel; Hämatologie.

During the past decade, Universitätsspital Basel; Hämatologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitätsspital Basel; Hämatologie" are "Chronic Lymphocytic Leukemia" (1 trials) and "Leukemia, Myeloid, Acute" (1 trials). Many other conditions were trialed in "Universitätsspital Basel; Hämatologie" in a lesser frequency.

Most popular intervention types in "Universitätsspital Basel; Hämatologie" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bendamustine" (1 trials), "Chlorambucil" (1 trials), "Cyclophosphamide" (1 trials), "Cytarabine" (1 trials) and "Fludarabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsspital Basel; Hämatologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsspital Basel; Hämatologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universitätsspital Basel; Hämatologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsspital Basel; Hämatologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".